Transcription Factor Activator Protein-1 (AP-1) Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMRMOA5681)
◆英語タイトル:Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMRMOA5681
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Transcription Factor Activator Protein-1 (AP-1) Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Transcription Factor Activator Protein-1 (AP-1) Inhibitors-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Transcription Factor Activator Protein-1 (AP-1) Inhibitors. This report provides information on the therapeutic development based on the Transcription Factor Activator Protein-1 (AP-1) Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Transcription Factor Activator Protein-1 (AP-1) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Transcription Factor Activator Protein-1 (AP-1) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Transcription Factor Activator Protein-1 (AP-1) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

*** レポート目次(コンテンツ)***

• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Overview
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Disease Associated
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Pipeline Therapeutics
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Therapeutics under Development by Companies
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors – Discontinued Products
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Transcription Factor Activator Protein-1 (AP-1) Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Transcription Factor Activator Protein-1 (AP-1) Inhibitors by Therapy Area, 2015
• Number of Products under Development for Transcription Factor Activator Protein-1 (AP-1) Inhibitors, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Monotherapy Products
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Combination Products
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Route of Administration
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Stage and Route of Administration
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Molecule Type
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Stage and Molecule Type
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Therapeutics – Discontinued Products
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2015

• Number of Products under Development for Transcription Factor Activator Protein-1 (AP-1) Inhibitors by Therapy Area, 2015
• Number of Products under Development for Transcription Factor Activator Protein-1 (AP-1) Inhibitors, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Monotherapy Products
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Combination Products
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Route of Administration
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Stage and Route of Administration
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Molecule Type
• Transcription Factor Activator Protein-1 (AP-1) Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • イラク防衛産業:購買マーケット動向(~2018)
    SDI's "The Iraqi Defense Industry - Procurement Market Dynamics to 2018: Market Profile" is an essential source of information on imports and exports by key segments covering the defense industry in Iraq.
  • 世界のホイールトラクター市場2015
    The Global Wheeled Tractor Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Wheeled Tractor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Wheele …
  • ポルトガルの電気アキュムレータ(蓄圧器)市場(~2019):市場規模、動向、予測
    The report Electric Accumulator Market in Portugal to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for electric accumulators in Portugal. The research includes historic data from 2009 to 2015 and forecasts …
  • 世界及び中国のフルアジナム市場2017
    The 'Global and Chinese Fluazinam Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Fluazinam industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fluazinam manufacturers and is a …
  • ワイヤーラインサービスの世界市場2016-2022
    According to Stratistics MRC, the Global Wireline Services market is accounted for $17.35 billion in 2015 and is expected to reach $34.06 billion by 2022 growing at a CAGR of 10.1%. There is constant growth in the oil & gas exploration and production activities for finding new unconventional resourc …
  • 自動車用NVH(騒音・振動・ハーシュネス)材料の世界市場:ゴム、熱可塑性ポリマ、エンジニアリング樹脂
    The global Automotive NVH (Noise Vibration Harshness) materials market size, in terms of value, is projected to reach USD 11.6 Billion by 2020, growing at a CAGR of 5.4% between 2015 and 2020. The increased necessity to reduce noise and vibration from vehicles and governments’ regulations to make qu …
  • 手巻きたばこ市場:ポーランド
    Synopsis Smoking tobacco Poland provides an in-depth and strategic analysis of the market for RYO/MYO tobacco markets. The report establishes market size and structure, analyses trends and developments for the last 13 years with forecasts to 2022. Detailed information is provided on consumption tren …
  • GE Energy Financial Services, Inc.(代替エネルギー分野):企業投資動向
    Summary GE Energy Financial Services, Inc. (GE Energy) is a financial service providing company. The company’s products and solutions include debt, leases, preferred limited partnership, limited partnership, project equity and private equity. Its invests in sectors such as power generation, transmis …
  • ヨーロッパの脊椎固定(Spinal Fusion)医療機器市場
    MediPoint: Spinal Fusion - EU Analysis and Market Forecasts Summary Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success …
  • Aktienbrauerei Kaufbeuren AG:企業概要・分析
    Synopsis Canadean's "Aktienbrauerei Kaufbeuren AG - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, recent developments, key employees, …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMRMOA5681 )"Transcription Factor Activator Protein-1 (AP-1) Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)" (英文:Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。